New guidance for complex UTIs in kids The guidelines specifically for complicated infections cover diagnosis and management according to determining features.
New tool aims to reduce kids’ hospitalisations for UTI A world-first tool which determines a unique score of clinical features will help GPs decide the correct route of antibiotics for UTIs in children.
Adolescent repeat self-harm risks highlighted by study Analysis of NSW hospital presentations for self-harm underline the need for youth-specific early intervention, according to researchers.
TGA approves second COVID-19 vaccine for youngest children The Pfizer vaccine is now approved for use in children aged six months to five years, with Moderna already available to the age group.
TGA approves vaccine booster for primary school age children Pfizer’s COVID-19 vaccine has been given the green light as a booster for children aged 5–11, with ATAGI recommendations to follow.
ATAGI approves Moderna vaccine for at-risk young children Parents are advised not to contact vaccine providers until bookings open, following decision to approve vaccination for the youngest cohort.
Investigation into mystery hepatitis outbreaks escalates Hundreds of children across 20 countries have been impacted, resulting in a number of liver transplants and at least five deaths.
COVID vaccination for children aged 5–11 to begin in January Pfizer’s paediatric vaccine has received its final approval, with ATAGI’s clinical guidance recommending a dosage interval of eight weeks.
COVID-19 vaccines and children: What GPs need to know The TGA has paved the way for COVID-19 vaccination in children aged 5–11 from early next year. What part will general practice play?
How to access Medicare support for third COVID vaccine doses GPs can conduct suitability assessments and administer third doses with the same item numbers used for second doses.